29-10-2020 дата публикации
Номер: US20200339596A1
Принадлежит:
Described herein are compounds of the formula (I), as well as pharmaceutical compositions comprising such compounds, and methods for using such compounds/pharmaceutical compositions for treating neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis (MS). 8. A pharmaceutical composition comprising at least one compound of and a pharmaceutically acceptable excipient.9. A method for treating a neurodegenerative disease claim 1 , the method comprising administering a therapeutically effective amount of at least one compound of claim 1 , or a pharmaceutically acceptable salt claim 1 , polymorph claim 1 , prodrug claim 1 , solvate or clathrate thereof.10. The method of claim 9 , wherein the neurodegenerative disease is Alzheimer's disease claim 9 , Parkinson's disease claim 9 , Huntington's disease or multiple sclerosis (MS).11. A method for inhibiting caspase-6 with a compound that reacts with the sulfhydryl group (SH) on cysteine 246 of caspase-6 claim 9 , the method comprising contacting caspase-6 with an effective amount of said compound. This application claims the benefit of U.S. Provisional Patent Appl. Ser. No. 62/616,160, filed Jan. 11, 2018, which application is incorporated by reference as if fully set forth herein.Caspases comprise a family of cysteine protease enzymes with a well-known role as key mediators in apoptosis signaling pathways and cell disassembly. Interleukin converting enzyme (ICE), also known as Caspase-1, was the first identified caspase. In humans, 11 other known caspases have been further identified. Caspases have been classified in two general groups according to their effects: proapoptotic (caspase-2, 3, 6, 7, 8, 9, 10) and proinfiammatory (caspase-1, 4, 5, 11, 12) caspases. The proapoptotic caspases have been divided in initiators (caspase-2, 8, 9, 10) also known as group II, and executioners (caspase-3, 6, 7) of the apoptotic process or group III. The Interleukin ...
Подробнее